Insulin Resistance and Short-Term Mortality in Patients with Acute Myocardial Infarction
|Rafael Sanjuan1*, Maria L Blasco1, Arturo Carratala3, Alfonso Mesejo1, Julio Nunyez2, Vicente Bodi2 and Juan Sanchis2|
|1Coronary Care Unit, University Clinic Hospital of Valencia, Valencia, Spain|
|2Hemodynamic Unit, University Clinic Hospital of Valencia, Valencia, Spain|
|3Service of Clinical Chemistry, University Clinic Hospital of Valencia, Valencia, Spain|
|Corresponding Author :||Rafael Sanjuan
Coronary Care Unit
University Clinic Hospital of Valencia
AV Blasco Ibañez 17, Valencia 46010, Spain Tel: +34963862627
E-mail: [email protected]
|Received November 08, 2011; Accepted February 13, 2012; Published February 16, 2012|
|Citation: Sanjuan R, Blasco ML, Carratala A, Mesejo A, Nunyez J, et al. (2012) Insulin Resistance and Short-Term Mortality in Patients with Acute Myocardial Infarction. J Clinic Experiment Cardiol 3:179. doi:10.4172/2155-9880.1000179|
|Copyright: © 2012 Sanjuan R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at
Pubmed Scholar Google
Background: Homeostasis Model Assessment (HOMA) is a widely used index to study the role of insulin resistance (IR).Our objective has been to clarify if IR would predict short-term mortality in patients with acute myocardial infarction (AMI).
Methods: Observational prospective study in 518 consecutive patients with a clinical diagnosis of AMI with or without diabetes mellitus. We evaluated glucose and insulin levels at baseline in order to estimate IR and mortality. Association between IR and mortality was assessed by means of the Cox regression analysis, and discriminative accuracy of the multivariate model with the Harrell’s C statistic.
Results: In-hospital mortality was 6% (32/518 of patients). Using ROC curve, in non-diabetic patients, IR index >2.2 was the best cut-off for predicting in-hospital mortality with a sensitivity of 71% and specificity of 80% (AUC=0,710) (p=0,008). An IR>2.2 was present in 27% (140 patients) and this group had higher rates of NYHA>2, Body Mass Index ≥30, hypertension and diabetes mellitus. Harrell’s C statistic of 0.967 was obtained when an IR>2.2 was used in the model to predict mortality. Furthermore, mortality rose as IR values increased, from 3% IR<2 to 18% when IR>3.5. In multivariate adjusted hazard ratio analysis IR>2.2 was an independent factor for in-hospital mortality (HR=3.4; 1.2-9) (p=0.017) in addition to age >70 years (HR=3.2; 1.04-10) (p=0.04) and Killip class >1 (HR=4; 1.4-14) (p=0.012).
Conclusions:Beyond traditional cardiovascular risk factors, insulin resistance as assessed by HOMA index, seems to strongly influence prognosis and could be included in the routine clinical work up of patients with acute myocardial infarction.